Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 2
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.
Chen Y, Xu Y, Chi Y, Sun T, Gao Y, Dou X, Han Z, Xue F, Li H, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Wang W, Ma Y, Song Z, Gu J, Gong W, Yang R, Zhang L. Chen Y, et al. Signal Transduct Target Ther. 2024 Apr 23;9(1):102. doi: 10.1038/s41392-024-01793-5. Signal Transduct Target Ther. 2024. PMID: 38653983 Free PMC article. Clinical Trial.
Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial.
Chen Y, Xu Y, Huang Y, Sun T, Hu Y, Xue F, Peng X, Lai Y, Zhou Z, Zhou H, Zhou R, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Li H, Liu X, Ma Y, Song Z, Peng J, Yang R, Zhang L. Chen Y, et al. Am J Hematol. 2024 Jan;99(1):E22-E25. doi: 10.1002/ajh.27141. Epub 2023 Oct 26. Am J Hematol. 2024. PMID: 37883528 Clinical Trial. No abstract available.
Single-dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open-label, randomized noninferiority trial.
Wang P, Zhou R, Xue F, Zhou H, Bai J, Wang X, Ma Y, Song Z, Chen Y, Liu X, Fu R, Sun T, Ju M, Dai X, Dong H, Yang R, Liu W, Zhang L. Wang P, et al. Am J Hematol. 2024 Jan;99(1):28-37. doi: 10.1002/ajh.27128. Epub 2023 Oct 18. Am J Hematol. 2024. PMID: 37851608 Clinical Trial.
[Clinical and genetic analyses of hereditary factor Ⅴ deficiency cases].
Zhang DL, Xue F, Dou XQ, Liu XF, Fu RF, Chen YF, Liu W, Jia YJ, Wang YH, Xiao ZJ, Zhang L, Yang RC. Zhang DL, et al. Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):302-307. doi: 10.3760/cma.j.issn.0253-2727.2021.04.006. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33979974 Free PMC article. Chinese.
11 results